517 articles
Simón Méndez‐Ferrer
Simón Méndez-Ferrer is a Spanish hematology researcher, Professor of Transfusion Medicine at the University of Cambridge, known for his 2008 Nature finding that circadian rhythms regulate blood stem cell release.
Sol Sherry
Sol Sherry (1916–1993) was an American physician-scientist in cardiovascular medicine whose work on the fibrinolytic enzyme system laid the foundation for streptokinase and other clot-dissolving drugs.
Srđan Verstovšek
Srdan Verstovsek (Srđan Verstovšek) is a hematologist-oncologist, Chief Medical Officer of Kartos Therapeutics since 2023, formerly of MD Anderson, known for leading the COMFORT-I and MOMENTUM trials of the first myelofibrosis drugs.
Stanford Wessler
Stanford Wessler was an American physician-scientist in internal medicine who researched thrombosis at Harvard and Beth Israel Hospital, later led Jewish Hospital of St. Louis, and challenged Buerger's disease in 1960.
Stavroula Kousteni
Stavroula Kousteni is a physiologist at Columbia University, where she directs the Edward P. Evans Center for Myelodysplastic Syndromes and studies bone's hormonal role in metabolism and blood cancers.
Stephan Stilgenbauer
Stephan Stilgenbauer, born 1966, is a German hematologist-oncologist known for defining the prognostic role of genomic aberrations in CLL and leading pivotal venetoclax trials as head of the Comprehensive Cancer Center Ulm.
Stephanie J. Lee
Stephanie J. Lee, also known as Stephanie Lee, is an American hematologist at Fred Hutch Cancer Center known for research on chronic graft-versus-host disease and transplant survivorship.
Stephen D. Nimer
Stephen D. Nimer is an American physician-scientist who studies leukemia and blood formation and has directed the Sylvester Comprehensive Cancer Center in Miami since 2012.
Stephen H. Embury
Stephen H. Embury is an American hematologist and physician-scientist who joined UCSF in 1977, known for research on the molecular genetics of sickle cell disease and thalassemia and for founding Vanguard Therapeutics.
Stephen H. Robinson
Stephen H. Robinson (died 1998) was an American hematologist at Harvard Medical School and Beth Israel Hospital, known for work on heme metabolism, bilirubin formation, and the porphyrias.
Stephen J. Schuster
Stephen J. Schuster is an American hematologist-oncologist at the University of Pennsylvania who directs its Lymphoma Program and led the first CAR T-cell trial in lymphoma.
Stephen M. Ansell
Stephen M. Ansell (Stephen Ansell) is a South African–trained hematologist at Mayo Clinic who helped lead the trial that earned FDA approval of nivolumab for Hodgkin's lymphoma.
Steve P. Watson
Steve P. Watson is a British platelet biologist and Emeritus British Heart Foundation Professor at the University of Birmingham, known for establishing how the platelet collagen receptor GPVI signals.
Steven C. Clark
Steven C. Clark is an immunologist and hematopoiesis researcher at Genetics Institute in Cambridge, Massachusetts, known for cloning the colony-stimulating factors that regulate blood cell production.
Steven Kleinman
Steven H. Kleinman is a Canadian physician-researcher in transfusion medicine, Clinical Professor of Pathology at the University of British Columbia, who studies the risk that HIV and other pathogens spread through blood transfusion.
Steven P. Treon
Steven P. Treon is an American hematologist-oncologist who directs the Bing Center for Waldenström's Macroglobulinemia Research at Dana-Farber and is a Harvard Medical School professor of medicine.
Steven W. Pipe
Steven W. Pipe (Steven Wesley Pipe) is an American pediatric hematologist at the University of Michigan known for leading pivotal gene therapy trials in hemophilia.
Stuart C. Finch
Stuart C. Finch was an American hematologist at Yale University School of Medicine whose research ranged from leukemia and lupus to radiation-induced leukemia and sickle-cell trait.
Sundar Jagannath
Sundar Jagannath is a hematologist-oncologist and multiple myeloma specialist who is Professor of Medicine at the Icahn School of Medicine at Mount Sinai and led the STORM trial of selinexor.
Susan L. Stramer
Susan L. Stramer is an American blood-safety scientist and Vice President of Scientific Affairs at the American Red Cross, known for nucleic acid testing for HIV and hepatitis C.
Suzanne C. Cannegieter
Suzanne C. Cannegieter is a Dutch clinical epidemiologist and professor at Leiden University Medical Center, known for a landmark 1995 study of anticoagulation in mechanical heart valve patients.
Swee Lay Thein
Swee Lay Thein is a Malaysian-born hematologist at the US National Institutes of Health whose work on fetal hemoglobin enabled CRISPR gene therapy for sickle cell disease.
Tage Astrup
Tage Astrup (1908–November 2006) was a Danish biochemist who pioneered fibrinolysis research and proposed the haemostatic balance, the equilibrium between blood clotting and clot dissolution.
Takehisa Kitazawa
Takehisa Kitazawa (北沢久寿), born 1968, is a Japanese antibody researcher at Chugai Pharmaceutical who co-invented emicizumab (Hemlibra) for hemophilia A and shared the 2026 Lasker–DeBakey Award.
Thalia Papayannopoulou
Thalia Papayannopoulou is a hematologist and cell biologist at the University of Washington who showed fetal hemoglobin can be reactivated in adults and identified VLA-4's role in stem cell movement.
Theodore E. Warkentin
Theodore E. Warkentin is a Canadian clinical and laboratory hematologist at McMaster University and Hamilton General Hospital, best known for heparin-induced thrombocytopenia research and devising the 4Ts scoring system.
Thierry Façon
Thierry Façon (born 1959) is a French hematologist and professor who heads the hematology service at CHU de Lille, known for leading myeloma trials including FIRST, MAIA, and IMROZ.
Thomas E. Witzig
Thomas E. Witzig is an American hematologist-oncologist and professor at Mayo Clinic in Rochester, Minnesota, known for pivotal trials of yttrium-90 ibritumomab tiuxetan radioimmunotherapy in lymphoma.
Thomas J. Kipps
Thomas J. Kipps (Thomas James Kipps) is an American hematologist-oncologist at UC San Diego whose work on chronic lymphocytic leukemia established ZAP-70 as a prognostic marker and advanced ibrutinib and ROR1-targeted therapy.
Thomas P. Duffy
Thomas P. Duffy (1937–2022) was an American hematologist and medical ethicist who taught at Yale School of Medicine for 38 years and initiated the New England Journal of Medicine's "Clinical Reasoning" essays.